PAMP
RAPT

Polar Asset Management Partners’s RAPT Therapeutics RAPT Stock Holding History

Polar Asset Management Partners’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,813
Closed -$418K – 810
2024
Q1 		$418K Sell
5,813
-18,437
-76% -$2.56M 0.01% 473
2023
Q4 		$4.82M Sell
24,250
-34,400
-59% -$4.26M 0.08% 222
2023
Q3 		$7.8M Buy
58,650
+7,800
+15% +$1.27M 0.17% 159
2023
Q2 		$7.61M Buy
50,850
+11,362
+29% +$1.77M 0.14% 192
2023
Q1 		$5.8M Buy
+39,488
New +$7.99M 0.09% 311

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Polar Asset Management Partners's RAPT Position: Q2 2024 in Review

Polar Asset Management Partners sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 5,813 shares — an estimated $418K sold.

Polar Asset Management Partners first reported a position in RAPT in Q1 2023 and held it in 5 quarters. The position peaked at $7.8M in Q3 2023. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • Polar Asset Management Partners reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 5,813 RAPT Therapeutics shares in Q2 2024, an estimated $418K.
  • Polar Asset Management Partners first reported a position in RAPT Therapeutics in Q1 2023 and held it in 5 quarters.
  • Polar Asset Management Partners's RAPT Therapeutics position peaked at $7.8M in Q3 2023.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on Polar Asset Management Partners's 13F filing for Q2 2024, filed 14 Aug 2024.